Group 1 - The core viewpoint of the report indicates that the pharmaceutical and communication sectors performed well during the period, while the overall market saw declines in major indices [2][8][13] - The report highlights that the average return of actively managed equity funds decreased by 0.26%, while actively managed bond funds saw a slight increase of 0.08% [2][16] - The report notes that the long-term pure bond funds outperformed other bond categories, with an average return of 0.15% for the period [16][17] Group 2 - The report identifies that the pharmaceutical sector has shown strong performance, with several actively managed equity funds focused on this sector achieving high returns [14][15] - The report provides a detailed analysis of various fund categories, indicating that the average return for QDII funds varied significantly, with energy commodity QDII funds leading at 4.54% [18][20] - The report emphasizes that the average return for the equity funds in the Greater China region was notably high at 33.16% for the year [18][20]

Core Insights - The report highlights a strategic update on fund allocation, focusing on active management equity products, fixed income plus products, pure bond products, and ETFs, indicating a diversified approach to investment [5][8][11]. Fund Strategy Update - The report proposes the inclusion of several active management equity funds such as Changcheng Pharmaceutical Industry Select A, Huatai-PB Hong Kong Advantage Select A, and others, reflecting a focus on sectors like healthcare and technology [5][8]. - Fixed income plus products recommended include Yongying Xinxin A and E Fund Enhanced Return A, aiming to balance risk and return [9]. - Pure bond and bond index products suggested are Pengyang Lifeng Short Bond A and Zhongjin Interbank Certificate Index 7-Day Holding, indicating a conservative approach to fixed income investments [10]. - ETFs recommended include Digital Economy ETF ICBC and Sci-Tech Innovation Index ETF E Fund, targeting growth sectors [11]. Portfolio Performance Tracking - As of July 28, 2025, the overall portfolio yield is reported at 9.48%, with a maximum drawdown of -5.21%, indicating a relatively stable performance in a volatile market [6][15]. - The aggressive portfolio shows a yield of 10.71% with a maximum drawdown of -5.52%, suggesting higher risk tolerance and potential for greater returns [6][15]. - The conservative portfolio yields 4.06% with a maximum drawdown of -1.77%, reflecting a low-risk strategy [6][15]. Adjustments to Core Positions - As of the end of July 2025, adjustments to the four major fund portfolios are planned, focusing on sectors such as AI, consumer goods, and fixed income [18][19][20][21]. - Specific funds being added include E Fund Strategic Emerging Industry A and Guangfa Value Core A for the monthly report portfolio, indicating a shift towards growth-oriented investments [18]. - The aggressive portfolio will include Penghua Quality Governance LOF and Yongying Yixiang A, while the conservative portfolio will add Ruiyuan Stable Benefit Enhanced 30-Day Holding A, showcasing a strategic shift towards stability and quality [19][21].

证券投资基金研究报告/基金周报 报告日期：2025年07月07日 本期（2025.6.30-2025.7.4）上证指数上涨 1.40%，深证成指上涨 1.25%。申万一级行业涨多跌少，其中钢铁和建筑材料行业表现较好。 海外权益市场重要指数涨多跌少，国际黄金价格上涨。本期各类型基金 均上涨。主动投资股票基金较上期上涨 1.82%，主动投资混合基金上涨 1.25%，主动投资债券基金上涨 0.17%；QDII 基金较上期上涨 0.63%。 图 1、基金指数近一年收益率走势 数据来源：wind，上海证券基金评价研究中心； 起止时间：2024 年 7 月 5 日——2025 年 7 月 4 日 图 2、各类型基金本期收益率（%） 数据来源：wind，上海证券基金评价研究中心；数据截至 2025 年 7 月 4 日 注：主动投资股票基金、混合基金及债券基金平均收益率采用中国开放式主动管理基 金系列指数收益率；其他类型基金平均收益率采用样本基金收益率算术平均值 分析师：池云飞 执业证书编号：S0870521090001 电话：021-53686397 E-mail: chiyunfei@shzq.com 研究助理：汪雪凝 ...

Core Insights - The report indicates that the environmental protection sector performed well during the period, with QDII funds showing an average return that outperformed other fund types [1][7][17] - The Shanghai Composite Index experienced a slight decline of 0.03%, while the Shenzhen Component Index fell by 0.91% during the same period [1] - Among various fund types, QDII funds increased by 1.04%, contrasting with declines in actively managed stock funds, mixed funds, and bond funds [1] Fund Performance Summary - The environmental and pharmaceutical sectors were highlighted as strong performers in the recent 12 periods, with banks and beauty care also showing good performance [7] - Active stock funds focusing on the pharmaceutical sector yielded higher returns, with notable funds such as Hongtu Innovation Healthcare Stock Fund achieving a return of 9.67% [12][13] - In the bond market, convertible bond funds led with an average return of 3.90% year-to-date, while traditional bond funds showed mixed results [15][16] QDII Fund Insights - REITs QDII funds led the performance with a return of 2.41%, followed by equity funds focused on Europe and the US, which returned 1.70% [17][18] - The report notes that alternative asset classes, particularly gold-related QDII funds, have shown significant year-to-date growth of 25.91% despite a recent decline of 1.39% [17][18] - Representative QDII funds such as Morgan China Biopharmaceutical A and GF CSI Hong Kong Innovative Medicine ETF reported returns of 4.72% and 4.56%, respectively, during the period [19]